Kraig Biocraft Laboratories (KBLB) Non-Current Debt (2010 - 2023)

Kraig Biocraft Laboratories (KBLB) has 10 years of Non-Current Debt data on file, last reported at $6.3 million in Q3 2023.

• For the quarter ending Q3 2023, Non-Current Debt rose 5336.84% year-over-year to $6.3 million; the trailing twelve-month figure through Sep 2023 stood at $6.3 million (up 5336.84% YoY), and the FY2022 full-year result was $5.7 million, up 5900.39% from the prior year.
• Non-Current Debt grew to $6.3 million in Q3 2023, from $6.0 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $6.3 million in Q3 2023 to a low of $62622.0 in Q1 2022.
• A 5-year average of $1.4 million and a median of $155244.0 in 2020 frame the typical range for Non-Current Debt.
• Across the five-year window, Non-Current Debt slumped 53.7% in 2022 and soared 9216.99% in 2023, its largest moves.
• Tracing KBLB's Non-Current Debt over 5 years: stood at $185244.0 in 2019, then declined by 21.59% to $145244.0 in 2020, then sank by 34.42% to $95244.0 in 2021, then soared by 5900.39% to $5.7 million in 2022, then rose by 9.63% to $6.3 million in 2023.
• Business Quant data shows KBLB's Non-Current Debt at $6.3 million in Q3 2023, $6.0 million in Q2 2023, and $5.8 million in Q1 2023.